FDA.reportPublic FDA data

safinamide 50 MG Oral Tablet [Xadago]

RxCUI
1922472
RxNorm name
safinamide 50 MG Oral Tablet [Xadago]
Display name
safinamide 50 MG Oral Tablet [Xadago]
Full name
safinamide 50 MG Oral Tablet [Xadago]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c4d65f28-983f-42b4-bb23-023ae0fe81b2Xadago 50 MG Oral Tablet [PSN] · safinamide 50 MG Oral Tablet [Xadago] [SBD] · Xadago 50 MG (as safinamide mesylate 65.88 MG) Oral Tablet [SY] · Xadago 50 MG Oral Tablet [SY]420These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 201720251022